Tobe T - Search Results

1

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy.

Yamasaki S, Kan N, Mise K, Harada T, Ichinose Y, Moriguchi Y, Kodama H, Satoh K, Ohgaki K, Tobe T. Yamasaki S, et al. Among authors: tobe t. Biotherapy. 1993;6(1):63-71. doi: 10.1007/BF01877387. Biotherapy. 1993. PMID: 8507545

2

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.

Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, Hori T, Ohgaki K, Tobe T. Satoh K, et al. Among authors: tobe t. Biotherapy. 1993;6(1):41-9. doi: 10.1007/BF01877385. Biotherapy. 1993. PMID: 8507544

3

Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.

Nio Y, Tsubono M, Tseng CC, Morimoto H, Kawabata K, Masai Y, Shiraishi T, Imai S, Ohgaki K, Tobe T. Nio Y, et al. Among authors: tobe t. Biotherapy. 1992;4(2):117-28. doi: 10.1007/BF02171756. Biotherapy. 1992. PMID: 1622733 Clinical Trial.

4

A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapy.

Satoh K, Kan N, Okino T, Nakanishi M, Mise K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Satoh K, et al. Among authors: tobe t. Cancer Immunol Immunother. 1991;32(5):273-9. doi: 10.1007/BF01789044. Cancer Immunol Immunother. 1991. PMID: 1998969 Free PMC article.

5

Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytes.

Nakanishi M, Kan N, Okino T, Satoh K, Mise K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Nakanishi M, et al. Among authors: tobe t. Biotherapy. 1990;2(1):21-32. doi: 10.1007/BF02172073. Biotherapy. 1990. PMID: 2119201

6

Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.

Nio Y, Ohgaki K, Tsuchitani T, Imai S, Shiraishi T, Tobe T. Nio Y, et al. Among authors: tobe t. Biotherapy. 1990;2(3):213-22. doi: 10.1007/BF02173522. Biotherapy. 1990. PMID: 2206774 Clinical Trial.

7

[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy].

Kan N, Okino T, Satoh K, Mise K, Teramura Y, Yamasaki S, Harada T, Ohgaki K, Tobe T. Kan N, et al. Among authors: tobe t. Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1421-7. Gan To Kagaku Ryoho. 1990. PMID: 2389941 Japanese.

8

Effect of heat treatment on tumor cells and antitumor effector cells.

Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Mise K, et al. Among authors: tobe t. Cancer Res. 1990 Oct 1;50(19):6199-202. Cancer Res. 1990. PMID: 2400985

9

Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.

Kan N, Okino T, Nakanishi M, Sato K, Mise K, Yamasaki S, Teramura Y, Ohgaki K, Tobe T. Kan N, et al. Among authors: tobe t. Biotherapy. 1989;1(3):197-206. doi: 10.1007/BF02170888. Biotherapy. 1989. PMID: 2642023

10

In vivo and in vitro synergistic antitumor effect of interleukin-2-cultured tumor-bearer spleen cells and immune fresh spleen cells.

Kan N, Okino T, Nakanishi M, Satoh K, Ohgaki K, Tobe T. Kan N, et al. Among authors: tobe t. Cancer Immunol Immunother. 1989;28(4):260-6. doi: 10.1007/BF00205235. Cancer Immunol Immunother. 1989. PMID: 2784714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

763 results

Search Page

Filters